SCHEMBL7531095

SCHEMBL7531095

Nc1cc(C(=O)O)cc(-c2[c]cccc2N)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 4/20 0.37
KDM4E B2RXH2 4/20 0.34
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
ALDH1A1 P00352 2/20 0.34
KMO O15229 1/20 0.34
LMNA P02545 1/20 0.34
DDO Q99489 1/20 0.34
LDHA P00338 1/20 0.34
PRKDC P78527 1/20 0.34
PBRM1 Q86U86 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MCL1 Q07820 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
THRB P10828 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CDC25B P30305 1/20 0.32
SYK P43405 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6757857 0.77 DHODH (0.39) DHODHPRKDCMCL1
SCHEMBL1142393 0.74 KDM4E (0.50) DHODHKDM4EKMT2AMEN1ALDH1A1
SCHEMBL1510201 0.74 DHODH (0.45) DHODHKDM4EKMT2AMEN1ALDH1A1
SCHEMBL2726729 0.73 DHODH (0.65) DHODHKMOPBRM1
SCHEMBL6138475 0.72 MAOA (0.47) KDM4EKMT2AMEN1ALDH1A1LMNA
SCHEMBL6607475 0.70 CYP3A4 (0.46) KDM4EKMT2AMEN1ALDH1A1LMNA
SCHEMBL31489168 0.70 DHODH (0.57) DHODHKDM4EKMT2AMEN1ALDH1A1
SCHEMBL20612659 0.70 KMO (0.63) DHODHKMOLMNAGAA
SCHEMBL30956238 0.70 RXRA (0.60) DHODHKDM4ELMNAHSD17B10
SCHEMBL29264797 0.70 RXRA (0.60) DHODHKDM4ELMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020198199-A1 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION 2002-12-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020198199-A1 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade TFPI, F2, PLAT DHODH 995/4885KDM4E 2122/4885KMT2A 3534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.